These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8181029)

  • 21. Skeletal muscle reperfusion injury is mediated by neutrophils and the complement membrane attack complex.
    Kyriakides C; Austen W; Wang Y; Favuzza J; Kobzik L; Moore FD; Hechtman HB
    Am J Physiol; 1999 Dec; 277(6):C1263-8. PubMed ID: 10600778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ischaemia-reperfusion is an event triggered by immune complexes and complement.
    Chan RK; Ibrahim SI; Verna N; Carroll M; Moore FD; Hechtman HB
    Br J Surg; 2003 Dec; 90(12):1470-8. PubMed ID: 14648724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement activation during sepsis in humans.
    Schreiber H; Rittirsch D; Flierl M; Brueckner U; Schneider M; Weiss M; Gebhard F; Huber-Lang M
    Adv Exp Med Biol; 2006; 586():217-26. PubMed ID: 16893075
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapeutic uses of recombinant complement protein inhibitors.
    Kalli KR; Hsu P; Fearon DT
    Springer Semin Immunopathol; 1994; 15(4):417-31. PubMed ID: 8153875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia- reperfusion injury.
    Squadrito F; Altavilla D; Squadrito G; Saitta A; Deodato B; Arlotta M; Minutoli L; Quartarone C; Ferlito M; Caputi AP
    J Mol Cell Cardiol; 2000 Mar; 32(3):429-40. PubMed ID: 10731442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury.
    Buerke M; Prüfer D; Dahm M; Oelert H; Meyer J; Darius H
    J Pharmacol Exp Ther; 1998 Jul; 286(1):429-38. PubMed ID: 9655888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement proteins and complement inhibitors in Alzheimer's disease.
    McGeer PL; McGeer EG
    Res Immunol; 1992; 143(6):621-4. PubMed ID: 1455053
    [No Abstract]   [Full Text] [Related]  

  • 28. Attenuation of interleukin-8 expression in C6-deficient rabbits after myocardial ischemia/reperfusion.
    Kilgore KS; Park JL; Tanhehco EJ; Booth EA; Marks RM; Lucchesi BR
    J Mol Cell Cardiol; 1998 Jan; 30(1):75-85. PubMed ID: 9500866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitors of the complement system currently in development for cardiovascular disease.
    Pugsley MK; Abramova M; Cole T; Yang X; Ammons WS
    Cardiovasc Toxicol; 2003; 3(1):43-70. PubMed ID: 12668890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TP20 is superior to TP10 in reducing ischemia/reperfusion injury in rat lung grafts.
    Schmid RA; Hillinger S; Hamacher J; Stammberger U
    Transplant Proc; 2001; 33(1-2):948-9. PubMed ID: 11267139
    [No Abstract]   [Full Text] [Related]  

  • 31. Complement inhibition attenuates human lung transplant reperfusion injury: a multicenter trial.
    Zamora MR; Davis RD; Keshavjee SH; Schulman L; Levin J; Ryan U; Patterson GA
    Chest; 1999 Jul; 116(1 Suppl):46S. PubMed ID: 10424589
    [No Abstract]   [Full Text] [Related]  

  • 32. Dermatan disulfate (Intimatan) prevents complement-mediated myocardial injury in the human-plasma-perfused rabbit heart.
    Hong TT; White AJ; Lucchesi BR
    Int Immunopharmacol; 2005 Feb; 5(2):381-91. PubMed ID: 15652767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do neutrophils contribute to the clearance of injured cardiomyocytes in reperfusion injury?
    Beranek JT
    J Pathol; 1997 Sep; 183(1):124-5. PubMed ID: 9370958
    [No Abstract]   [Full Text] [Related]  

  • 34. Membrane regulators of complement activation and their aberrant expression in disease.
    Asghar SS
    Lab Invest; 1995 Mar; 72(3):254-71. PubMed ID: 7898046
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical complementology: recent progress and future trends.
    Morgan BP
    Eur J Clin Invest; 1994 Apr; 24(4):219-28. PubMed ID: 8050450
    [No Abstract]   [Full Text] [Related]  

  • 36. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs.
    Amsterdam EA; Stahl GL; Pan HL; Rendig SV; Fletcher MP; Longhurst JC
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H448-57. PubMed ID: 7840295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of complement and perspectives for intervention in transplantation.
    Chen G; Chen S; Chen X
    Immunobiology; 2013 May; 218(5):817-27. PubMed ID: 23182708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do neutrophils contribute to myocardial reperfusion injury?
    Lefer DJ
    Basic Res Cardiol; 2002 Jul; 97(4):263-7. PubMed ID: 12212545
    [No Abstract]   [Full Text] [Related]  

  • 39. Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition.
    Schwertz H; Carter JM; Russ M; Schubert S; Schlitt A; Buerke U; Schmidt M; Hillen H; Werdan K; Buerke M
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):151-60. PubMed ID: 18670364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombolysis: adjuvant therapy and the role of complement.
    Fox KA
    Eur Heart J; 1990 Aug; 11 Suppl F():36-42. PubMed ID: 2226539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.